Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent

Perrigo is launching generic of J&J’s OTC Imodium Multi-Symptom Relief product for diarrhea and gas. An analyst estimates the product could generate $15m in annualized sales.

More from United States

More from North America